B. Hernández-Santiago

发表

The discovery of IDX21437: Design, synthesis and antiviral evaluation of 2'-α-chloro-2'-β-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitors.

J. Bilello, S. Cappelle, I. Serra, 2017, Bioorganic & medicinal chemistry letters.

Ribonucleoside Analogue That Blocks Replication of Bovine Viral Diarrhea and Hepatitis C Viruses in Culture

M. Otto, L. Stuyver, R. Schinazi, 2003, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of the Antiviral Agent β-d-2′-Deoxy-2′-Fluoro-2′-C-Methylcytidine in Rhesus Monkeys

R. Schinazi, S. Hurwitz, Junxing Shi, 2007, Antimicrobial Agents and Chemotherapy.

Anti-Human Immunodeficiency Virus Activity, Cross-Resistance, Cytotoxicity, and Intracellular Pharmacology of the 3′-Azido-2′,3′-Dideoxypurine Nucleosides

J. Mellors, R. Schinazi, N. Sluis-Cremer, 2009, Antimicrobial Agents and Chemotherapy.

The Boron–Neutron Capture Agent β-d-5-o-Carboranyl-2′-deoxyuridine Accumulates Preferentially in Dividing Brain Tumor Cells

R. Schinazi, S. Hurwitz, Chalet Tan, 2005, Journal of Neuro-Oncology.

Pharmacology and Pharmacokinetics of the Antiviral Agent β-d-2′,3′-Dideoxy-3′-Oxa-5-Fluorocytidine in Cells and Rhesus Monkeys

H. McClure, R. Schinazi, C. K. Chu, 2005, Antimicrobial Agents and Chemotherapy.

Antiviral and Cellular Metabolism Interactions 4 between Dexelvucitabine and Lamivudine 5 6

R. Schinazi, K. Rapp, Judy S. Mathew, 2007 .

Mechanism of Anti-Human Immunodeﬁciency Virus Activity of (cid:2) - D -6-Cyclopropylamino-2 (cid:3) ,3 (cid:3) -Didehydro-2 (cid:3) ,3 (cid:3) -Dideoxyguanosine

K. Anderson, R. Schinazi, C. K. Chu, 2005 .

Pharmacology of β-l-Thymidine and β-l-2′-Deoxycytidine in HepG2 Cells and Primary Human Hepatocytes: Relevance to Chemotherapeutic Efficacy against Hepatitis B Virus

J. Rodríguez-Orengo, J. Imbach, J. Sommadossi, 2002, Antimicrobial Agents and Chemotherapy.

Pharmacology of beta-L-thymidine and beta-L-2'-deoxycytidine in HepG2 cells and primary human hepatocytes: relevance to chemotherapeutic efficacy against hepatitis B virus.

J. Rodríguez-Orengo, J. Imbach, J. Sommadossi, 2002, Antimicrobial Agents and Chemotherapy.

Nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.

R. Schinazi, P. L. Sharma, B. Hernández-Santiago, 2004, Current topics in medicinal chemistry.

Pharmacology of current and promising nucleosides for the treatment of human immunodeficiency viruses.

R. Schinazi, S. Hurwitz, Raymond F Schinazi, 2006, Antiviral research.

Metabolism of the Anti-Hepatitis C Virus Nucleoside β-d-N4-Hydroxycytidine in Different Liver Cells

L. Stuyver, R. Schinazi, C. K. Chu, 2004, Antimicrobial Agents and Chemotherapy.

Mechanism of Anti-Human Immunodeficiency Virus Activity of β-d-6-Cyclopropylamino-2′,3′-Didehydro-2′,3′-Dideoxyguanosine

K. Anderson, H. McClure, R. Schinazi, 2005, Antimicrobial Agents and Chemotherapy.

Metabolism of the Anti-Hepatitis C Virus Nucleoside β-d-N4-Hydroxycytidine in Different Liver Cells

L. Stuyver, R. Schinazi, C. K. Chu, 2004, Antimicrobial Agents and Chemotherapy.

Antiviral and Cellular Metabolism Interactions between Dexelvucitabine and Lamivudine

R. Schinazi, K. Rapp, Judy S. Mathew, 2007, Antimicrobial Agents and Chemotherapy.

Cellular Pharmacology of 9-(β-D-1,3-dioxolan-4-yl) Guanine and its Lack of Drug Interactions with Zidovudine in Primary Human Lymphocytes

R. Schinazi, S. Hurwitz, Emilie Fromentin, 2007, Antiviral chemistry & chemotherapy.

Long-Term Exposure to AZT, but not d4T, Increases Endothelial Cell Oxidative Stress and Mitochondrial Dysfunction

Dean P. Jones, R. Schinazi, S. Dikalov, 2009, Cardiovascular Toxicology.

Erratum to “Pharmacology of current and promising nucleosides for the treatment of human immunodeficiency viruses” [Antiviral Res. 71 (2006) 322–334]

R. Schinazi, S. Hurwitz, B. Hernández-Santiago, 2006 .